ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

MGX Metagenomi Inc

8.10
0.00 (0.00%)
Pre Market
Last Updated: 04:09:30
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 3.26
Ask Price 10.73
News -
Day High

Low
6.50

52 Week Range

High
12.74

Day Low
Company Name Stock Ticker Symbol Market Type
Metagenomi Inc MGX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 8.10 04:09:30
Open Price Low Price High Price Close Price Prev Close
8.10
Trades Volume Avg Volume 52 Week Range
0 0 - 6.50 - 12.74
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 8.10 USD

Metagenomi Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
303.97M 37.53M - 44.76M -68.26M -1.82 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Metagenomi News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No MGX Message Board. Create One! See More Posts on MGX Message Board See More Message Board Posts

Historical MGX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week6.598.3956.507.10164,6411.5122.91%
1 Month10.7911.016.508.15115,452-2.69-24.93%
3 Months10.2512.746.5010.62193,290-2.15-20.98%
6 Months10.2512.746.5010.62193,290-2.15-20.98%
1 Year10.2512.746.5010.62193,290-2.15-20.98%
3 Years10.2512.746.5010.62193,290-2.15-20.98%
5 Years10.2512.746.5010.62193,290-2.15-20.98%

Metagenomi Description

At Metageno­mi, we are cre­at­ing poten­tial­ly cura­tive ther­a­peu­tics using our metage­­nomics-pow­ered genome edit­ing toolbox.We believe tools with capa­bil­i­ties that go beyond the cur­rent tech­nol­o­gy land­scape will be required in order to reach the full ther­a­peu­tic poten­tial of genome edit­ing. By har­ness­ing the pow­er of metage­nomics, the study of genomes recov­ered from uncul­ti­vat­ed organ­isms in the nat­ur­al envi­ron­ment, we are dis­cov­er­ing and devel­op­ing asuite of nov­el genome edit­ing tools with the poten­tial to make any desired ther­a­peu­tic gene edit, any­where in the human genome.

Your Recent History

Delayed Upgrade Clock